US57777K1060
US57777K1060
MaxCyte, Inc.
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 104.24M EUR | 130.54M EUR | 75.31M EUR | 165.52M EUR |
Enterprise Value | 16.83M EUR | 132.75M EUR | 78.24M EUR | 163.4M EUR |
Valuation Multiples | ||||
Trailing P/E | -- | -- | -- | -- |
Forward P/E | -4.12x | -- | -- | -- |
Price to Sales | 3.36x | 4.2x | 2.33x | 7.31x |
Price to Book | 0.68x | 0.82x | 0.45x | 0.97x |
EV/Revenue | 0.54x | 4.28x | 2.42x | 7.22x |
EV/EBITDA | -0.56x | -- | -- | -- |
Price to FCF (P/FCF) | -- | -- | -- | -- |
EV/FCF | -- | -- | -- | -- |
FCF Yield | -12.6% | -18.23% | -39.18% | -12.76% |